Ascletis Pharma Inc. (FRA:2VJ)
Germany · Delayed Price · Currency is EUR 1.390
-0.030 (-2.11%)
At close: Jan 30, 2026
Ascletis Pharma Market Cap
Ascletis Pharma has a market cap or net worth of €1.47 billion as of January 30, 2026. Its market cap has increased by 298.73% in one year.
Market Cap
1.47B
Enterprise Value
1.26B
Revenue
280.99K
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.39
Market Cap Chart
Since August 1, 2018, Ascletis Pharma's market cap has decreased from 1.71B to 1.47B, a decrease of -14.32%. That is a compound annual growth rate of -2.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 1.47B | 19.33% |
| Dec 31, 2025 | 1.23B | 240.64% |
| Dec 31, 2024 | 361.09M | 104.81% |
| Dec 29, 2023 | 176.31M | -71.49% |
| Dec 30, 2022 | 618.38M | 53.38% |
| Dec 31, 2021 | 403.17M | 21.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.50B |
| Mainova AG | 2.40B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.82B |
| tonies SE | 1.18B |
| Sedlmayr Grund und Immobilien AG | 983.95M |
| Berliner Effektengesellschaft AG | 886.48M |
| Northern Data AG | 815.94M |